Rounded Bottom Reversal Pattern & Fundamental Developments Could See The Bulls Back In This Microcap

Sponsored:

Wednesday, February 16, 2022

There are certain nutrients that are essential to live on Earth, albeit a human or a tomato plant. One of those nutrients is copper. What is known today about utilizing copper to revolutionize the textile products industry is only scratching the surface for potential applications, according to BioLife Sciences Inc. (OTCPK: BLFE) Chief Operating Officer Nika Jaksic. She envisions using cutting edge copper infusion technology across a swath of industries, and as head of the BioLife’s newly formed Life Sciences division, she’ll have a chance to pioneer innovation in the space.

Jaksic was previously CEO of Health Box LLC, an Arizona-based orthomolecular medicine and natural health products company. She made the transition to BioLife COO this month upon the completion of an all-stock transaction in which BioLife acquired Health Box.

BioLife is an upstart specialized in moving products from small-scale production into wider market adoption, with its core offerings centered on developing, licensing, and distributing antimicrobial products and its disruptive MFusion copper-infusion technology. Bringing Health Box into the fold added orthomolecular medicines and products, including micronutrients, medicinal herbal supplements, botanicals, holistic merchandises, and a cannabidiol (CBD) subscription service.

MFusion is a proprietary technology that stands out from conventional copper infusion techniques by directly connecting copper metal ions to every sub-bundle of a textile. Coverage at this nano-level endows all portions of the manufactured product to reap the wellness benefits of copper, rather than limited coverage with copper strands or coatings like MFusion’s competitors.

In humans, copper is found in all body tissues and is integral to red blood cell formation, collagen formation, energy, maintaining nerve cells and the immune system, amongst other things, including being utilized for anti-inflammatory, antibacterial, antifungal, and antiviral capabilities. Copper is known as a “contact killer” for many pathogens. For plants, copper is required in enzymatic activities for chlorophyll and seed production.

Armed with its new Health Box assets, BioLife is launching a Life Sciences unit, which will conduct R&D with the expectations of bringing to market a variety of unique horticultural and agricultural products and solutions. Jaksic will spearhead the new initiative, lending her expertise for the fusion of orthomolecular sciences and antimicrobial elemental metals towards breakthroughs in plant and gardening processes.

The company sees a tremendous unaddressed market available by marrying MFusion to orthomolecular science for pomology (growing fruit), olericulture (vegetable production and storage), floriculture (flower production and storage). “Outside of its well-known antiviral and antibacterial properties that can combat a variety of diseases, copper is also a vital micronutrient for both plants and humans. Its presence ensures healthy development, disease prevention and overall wellbeing,” said Jaksic.

To lend some color to the TAM (total addressable market), consider only the gardening market, which has experienced steady growth, rising from $88.5 billion in 2015 to cross $100 billion for the first time in 2020 when it reached $104 billion. According to Statista, the global market for garden equipment and supplies, will climb to nearly $130 billion in 2024. BioLife is now positioned to be in the thick of it with next-generation organic products that improve yields and plant quality.

From a stock chart perspective, shares of BLFE have pulled back of late after an impressive run that began in mid-November. We’re seeing what appears to be a rounded bottom (bullish reversal pattern) technical formation in the chart with strong support likely around $0.60 and $0.50. The 200-day moving average should also act as strong support, currently at $0.55. Point being, there are several major support levels in the vicinity of the current share price along with the developing reversal pattern that could act as insulators from further excessive downside risk. If the bulls can muster a bounce back, we would be looking at overhead resistance around $0.75 and $0.90. Then things could get really interesting with this stock.

--

BioLife Sciences Inc. (OTCPK: BLFE) Full Corporate Write-Up: Click Here.

--

About AllPennyStocks.com:

AllPennyStocks.com Media, Inc., founded in 1999, is one of North America’s largest and most comprehensive small-cap / penny stock financial portals. With Canadian and U.S. focused penny stock features and content, the site offers information for novice investors to expert traders. Outside of the countless free content available to visitors, AllPennyStocks.com Pro (premium service) caters to traders looking for that trading edge by offering monthly stock picks, daily penny stock to watch trade ideas, market commentary and more.

As a result of its commitment to journalistic excellence and abundance of information in a particular area of equity investing (micro-cap investing) where there aren’t many credible sources of information, AllPennyStocks.com continues to have one of the largest audiences of micro-cap investors on the internet.

Sponsored: